Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review-Reference-Cited by-同舟云学术

Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review

Published:2018-10-31 Issue:12 Volume:12 Page:1251-1263
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Puig-Junoy Jaume¹²³^ORCID,Pascual-Argente Natàlia²³^ORCID,Puig-Codina Lluc²,Planellas Laura⁴,Solozabal Míriam⁴

Affiliation:

1. Department of Economics and Business (UPF), Pompeu Fabra University, Barcelona, Spain

2. UPF Barcelona School of Management, Pompeu Fabra University, Barcelona, Spain

3. UPF Center for Research in Health and Economics (CRES-UPF), Pompeu Fabra University, Barcelona, Spain

4. Real-World Insights, IQVIA, Barcelona, Spain

Funder

IQVIA and Pompeu Fabra University

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2018.1540929

Reference56 articles.

1. Global Hepatitis Report. [Internet]. Geneva: World Health Organization; 2017. [2018 May, 29]. Available from: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1.

2. Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunistic screening for hepatitis C virus infection in an emergency department in Almeria, Spain;Emergencias;2023-12-22

2. The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: a ten-year analysis;The European Journal of Health Economics;2022-11-10

3. Value appropriation in hepatitis C;The European Journal of Health Economics;2021-12-02

4. dfgcompare: a library to support process variant analysis through Markov models;BMC Medical Informatics and Decision Making;2021-12

5. Determinants of HCV‐related complications in Italian primary care patients;Liver International;2021-07-26